CHO-4'Me-5'Br-FUBOXPYRA

The following information was compiled in June 2023 and is subject to change as new research is conducted and as new information becomes available:

Description: CHO-4'Me-5'Br-FUBOXPYRA is a novel synthetic cannabinoid. To date, no structurally similar drugs to CHO-4'Me-5'Br-FUBOXPYRA have been identified in the recreational drug supply. However, medicinal chemistry literature documents the synthesis and evaluation of other molecules from the its synthetic cannabinoid subclass, including an analogue with a cycloheptyl-containing head group. In early 2023, forensic laboratories in the United States shared their identifications of this novel synthetic cannabinoid, although the structure of CHO-4'Me-5'Br-FUBOXPYRA was not previously confirmed or reported. Due to its novelty, little information is currently known about CHO-4'Me-5'Br-FUBOXPYRA.

Sample Source: Pinellas County Forensic Lab (Largo, FL, USA).

Sample Appearance: Drug material – white powder.

Pharmacology: No information is available at this time.

Toxicology: CHO-4'Me-5'Br-FUBOXPYRA has not been detected in toxicology samples at the CFSRE.

Drug Materials: CHO-4'Me-5'Br-FUBOXPYRA has been identified in one drug material at the CFSRE.

Demographics / Geographics: The drug material originated from the state of Florida.

Legal Status: CHO-4'Me-5'Br-FUBOXPYRA is not explicitly scheduled in the United States.

Class:

Cannabinoid

Appearance:

White powder

Formula:

C20H22BrFN2O2

MW:

421.30

[M+]:

420

[M+H]+:

421.0921

IUPAC:

N-[5-bromo-1-[(4-fluorophenyl)methyl]-4-methyl-2-oxo-3-pyridyl]cyclohexanecarboxamide

Report Date:

June 28, 2023